Left maxillary sinus tumour‐induced hypophosphataemic osteomalacia and combined with thyroid papillary carcinoma: a case report and literature review

2020 ◽  
Vol 50 (6) ◽  
pp. 755-761
Author(s):  
Baoxin Li ◽  
Yuehua Dong ◽  
Dandan Liu ◽  
Qi Yao ◽  
Shuqin Guo ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Maxillary Sinus ◽  
Papillary Carcinoma ◽  
Thyroid Papillary Carcinoma ◽  
Thyroid Papillary ◽  
Left Maxillary Sinus ◽  
Hypophosphataemic Osteomalacia

scholarly journals Pneumatosis intestinalis in a radioactive iodine-refractory metastasic thyroid papillary carcinoma with BRAFV600E mutation treated with dabrafenib–trametinib: a case report

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
M. C. Martín-Soberón ◽  
S. Ruiz ◽  
G. De Velasco ◽  
R. Yarza ◽  
A. Carretero ◽  
...  
Keyword(s):  
Case Report ◽  
Papillary Carcinoma ◽  
Radioactive Iodine ◽  
Specific Treatment ◽  
Pneumatosis Intestinalis ◽  
Thyroid Papillary Carcinoma ◽  
Intestinal Pneumatosis ◽  
Abdominal Symptoms ◽  
Positron Emission ◽  
Thyroid Papillary

Abstract Background Pneumatosis intestinalis (PI) is a rare entity which refers to the presence of gas within the wall of the small bowel or colon which is a radiographic sign. The etiology and clinical presentation are variable. Patients with PI may present either with chronic mild non-specific symptoms or with acute abdominal pain with peritonitis. Some cases of intestinal pneumatosis have been reported as adverse events of new oncological treatments such as targeted therapies that are widely used in multiple tumors. Case presentation A 59-year-old caucasian female with radioactive iodine-refractory metastatic thyroid papillary carcinoma with BRAFV600E mutation was treated with dabrafenib and trametinib as a compassionate use. After 4 months treatment, positron emission tomography–computed tomography (PET–CT) showed PI. At the time of diagnosis, the patient was asymptomatic without signs of peritonitis. The initial treatment was conservative and no specific treatment for PI was needed. Unfortunately, after dabrafenib–trametinib withdrawal, the patient developed tumor progression with significant clinical worsening. Conclusions This case report is, in our knowledge, the first description of PI in a patient treated with dabrafenib–trametinib. Conservative treatment is feasible if there are no abdominal symptoms.

scholarly journals A Case Report of the Association Renal AA Amyloidosis and Thyroid Papillary Carcinoma

2018 ◽  
Vol 08 (02) ◽  
pp. 65-69
Author(s):  
Dione Diomaye Jean Pierre ◽  
Jmahri Hind ◽  
En-Niya Fatima ◽  
Al Hamany Zitouna ◽  
Bouattar Tarik ◽  
...  
Keyword(s):  
Case Report ◽  
Papillary Carcinoma ◽  
Thyroid Papillary Carcinoma ◽  
Aa Amyloidosis ◽  
Thyroid Papillary

scholarly journals Synchronous parathyroid adenoma and thyroid papillary carcinoma: a case report

Cases Journal ◽  
2009 ◽  
Vol 2 (1) ◽  
Author(s):  
Ioannis P Iakovou ◽  
Iordanis E Konstantinidis ◽  
Alexandra I Chrisoulidou ◽  
Argyrios S Doumas
Keyword(s):  
Case Report ◽  
Parathyroid Adenoma ◽  
Papillary Carcinoma ◽  
Thyroid Papillary Carcinoma ◽  
Thyroid Papillary

scholarly journals Functioning Thyroid Papillary Carcinoma: A case report

2006 ◽  
Vol 99 (1) ◽  
pp. 43-47
Author(s):  
Satoshi Ohno ◽  
Norio Yamamoto ◽  
Koichi Omori ◽  
Atsuhiro Yoshida ◽  
Yasuyuki Hiratsuka ◽  
...  
Keyword(s):  
Case Report ◽  
Papillary Carcinoma ◽  
Thyroid Papillary Carcinoma ◽  
Thyroid Papillary

scholarly journals Differentiated thyroid papillary carcinoma with cerebellar metastasis, case report

2016 ◽  
Author(s):  
Elif Turan ◽  
Ahmet Kaya ◽  
Mustafa Kulaksizoglu ◽  
Aysegul Zamani ◽  
Sumeyye Kozacioglu
Keyword(s):  
Case Report ◽  
Papillary Carcinoma ◽  
Thyroid Papillary Carcinoma ◽  
Thyroid Papillary ◽  
Cerebellar Metastasis
Sign in / Sign up

Export Citation Format

Share Document